c-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression

Area of Science:

• Neuroscience
• Molecular Biology
• Pain Research

Background:

• The transcription factor Fos and preprodynorphin messenger RNA (mRNA) are upregulated in the spinal cord following noxious stimuli.
• Dynorphin opioid peptides are implicated in pain modulation.

Purpose of the Study:

• To investigate the role of c-fos mRNA transcription in the formalin pain model.
• To determine the involvement of dynorphin peptides in formalin-induced nociception.

Main Methods:

• Intrathecal administration of antisense oligodeoxynucleotides targeting c-fos mRNA in rats.
• Intraplantar formalin injection to induce pain and inflammation.
• Measurement of Fos protein and preprodynorphin mRNA levels in the lumbar spinal cord.
• Assessment of formalin-induced behaviors (licking/biting).

Main Results:

• Antisense oligodeoxynucleotide pretreatment prevented formalin-induced increases in Fos protein and preprodynorphin mRNA.
• Saline or sense oligodeoxynucleotide pretreatment led to significant increases in Fos protein and preprodynorphin mRNA.
• Antisense pretreatment enhanced formalin-induced licking/biting responses during the tonic phase.

Conclusions:

• Upregulation of c-fos and subsequent preprodynorphin mRNA synthesis is a key event in the spinal cord's response to formalin.
• Dynorphin peptides, modulated by c-fos, likely play a role in the antinociceptive pathways.
• Targeting c-fos may offer a novel approach for pain management.